Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Zev A. Wainberg, MD

Advertisement

Articles by Zev A. Wainberg, MD

Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic Cancer

ByZev A. Wainberg, MD
February 10th 2023

Zev A. Wainberg, MD, discusses the implications of the findings from the phase 3 NAPOLI 3 trial for patients with metastatic pancreatic ductal adenocarcinoma.

Advertisement

Latest Updated Articles

  • Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic Cancer
    Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic Cancer

    February 10th 2023



Advertisement
Advertisement

Trending on Oncology Nursing News

1

GLP-1s and Breast Cancer: Navigating the Link Between Weight and Risk

2

How an Oncology Nurse Taught Shannon Miller to Find Her Strength

3

UCI Study: Infection Risks Found in Antibody-Drug Conjugate Therapy

4

Amivantamab/Lazertinib Shows 41-Month Survival in Atypical EGFR NSCLC: What Nurses Need to Know

5

Addressing Patients’ Sexual Health and Body Image in Oncology Nursing

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us